Skip to Main Content

Paper Details

CRISPR screens decode cancer cell pathways that trigger γδ T cell detection.
Nature
16
2023
AMP, AMP-activated protein kinase, AMPK, ATP, BTN2A1, BTN3A, BTN3A1, T cells, Tcell, Tcells, V9V2 Tcell receptor, V9V2 Tcells, butyrophilin 2A1, cancer, cancer cells, cell line model, human, human Tcells, human leukocyte antigen, patient, patient-derived tumour organoids, stressed target cells, transformed, transformed cells, tumour, tumour cells, tumours
Author NameAffiliation
Kristina HanspersInstitute of Data Science and Biotechnology, Gladstone Institutes
Jonathan K PritchardStanford University
Jonathan K PritchardStanford University
Alexander MarsonGladstone-UCSF Institute of Genomic Immunology
Alexander MarsonUniversity of California san francisco
Alexander MarsonDiabetes Center, University of California san francisco
Alexander MarsonUniversity of California san francisco
Alexander MarsonInnovative Genomics Institute, University of California-Berkeley
Alexander MarsonUCSF Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Alexander MarsonParker Institute for Cancer Immunotherapy, University of California san francisco
Alexander MarsonInstitute for Human Genetics, University of California san francisco
  • 1 - 11

Datasets

Release 1.2